Comparison of clinical with pathological nodal staging from systematic mediastinal lymph node dissection in early resectable non-small cell lung cancer

Singapore Medical Journal

Volumn 48, Issue 7, 2007, Pages 620-624

  Chong, Chee Fui ^a,e   Khoo, K L ^b   Lim, T K ^b   Chang, A Y ^d   Lim, H L ^c   Lee, C N ^a   Wong, P S ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b Department of Medicine

^c Department of Haematology Oncology ^*

^d Johns Hopkins Singapore   (Singapore)

^e RIPAS HOSPITAL   (Brunei Darussalam)

Author keywords

Lung carcinoma; Lymph node excision; Neoplasm staging; Non small cell lung cancer

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; LARGE CELL CARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; LYMPHOEPITHELIOMA; MALE; METASTASIS; PATIENT REFERRAL; SEX RATIO; SQUAMOUS CELL CARCINOMA; BIOPSY; COMPARATIVE STUDY; EVALUATION; LUNG TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; RADIOGRAPHY; RETROSPECTIVE STUDY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34547410805     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Carney DN. Lung cancer: time to move on from chemotherapy. N Engl J Med 2002; 346:126-8.
2. Sioris T, Jarvenpaa R, Kuukasjarvi P, et al. Comparison of computed tomography and systematic lymph node dissection in determining TNM and stage in non-small cell lung cancer. Eur J Cardiothorac Surg 2003; 23:403-8.
3. Finlay GA, Joseph B, Rodrigues CR, Griffith J, White AC. Advanced presentation of lung cancer in Asian immigrants: a case-control study. Chest 2002; 122:1938-43.
4. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of nonsmall cell lung cancer: a review of the current evidence. Chest 2003; 123(1 Suppl):137S-46S.
5. Fritscher-Ravens A, Bohuslavizki KH, Brandt L, et al. Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration. Chest 2003; 123:442-51.
6. Toloza EM, Harpole L, Detterbeck F, McCrory DC. Invasive staging of non-small cell lung cancer - a review of the current evidence. Chest 2003; 123:157S-66S.
7. Graham AN, Chan KJ, Pastorino D, Goldstraw P. Systematic nodal dissection in intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 1999; 117:246-51.
8. Izbicki JR, Passlick B, Hosch SB, et al. Mode of spread in the early phase of lymphatic metastasis in non-small cell lung cancer: significance of nodal micrometastasis. J Thorac Cardiovasc Surg 1996; 112:623-30.
9. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111:1718-23.
10. Watanabe Y, Hayashi Y, Shimizu J, Oda M, Iwa T. Mediastinal nodal involvement and the prognosis of non-small cell lung cancer. Chest 1991; 100:422-8.
11. Ludwig MS, Goodman M, Miller DL, Johnstone PA. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest 2005; 128:1545-50.
12. Fernando HC, Goldstraw P. The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathologic staging. Cancer 1990; 65:2503-6.
13. Robinson LA, Wagner H Jr, Ruckdeschel JC; American College of Chest Physicians. Treatment of stage IIIA non-small cell lung cancer. Chest 2003; 123(1 Suppl):202S-20S.
14. Cerfolio RJ, Qjha B, Bryant AS, et al. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg 2003; 76:861-6.
15. Roberts PF, Follette DM, von Haag D, et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 2000; 70:1154-9.
16. Gupta NC, Tamim WJ, Graeber GG, Bishop HA, Hobbs GR. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 2001;120:521-7.
17. von Haag DW, Follette DM, Roberts PF, et al. Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer. J Surg Res 2002; 103:160-4.
18. Kernstine KH, Mclaughlin KA, Menda Y, et al. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? Ann Thorac Surg 2002; 73:394-401.
19. Stevens H, Bakker PF, Schlosser NJ, van Rijk PP, de Klerk JM. Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers. J Nucl Med 2003; 44:336-40.
20. Graeter TP, Hellwig D, Hoffmann K, et al. Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. Ann Thorac Surg 2003; 75:231-5.